Sublytic membrane-attack-complex activation and VEGF secretion in retinal pigment epithelial cells

Advances in Experimental Medicine and Biology

Volumn 723, Issue , 2012, Pages 23-30

  Kunchithapautham, Kannan ^a   Bandyopadhyay, Mausumi ^a   Dahrouj, Mohammad ^a   Thurman, Joshua M ^b   Rohrer, Bärbel ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Age Related Macular Degeneration; Complement System; RPE Monolayer; Sublytic Activation; Transepithelial Resistance; VEGF

Indexed keywords

ANTIOXIDANT; BEVACIZUMAB; COMPLEMENT; FERRIC AMMONIUM CITRATE; IRON; PEGAPTANIB; RANIBIZUMAB; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; VASCULOTROPIN; ZINC;

CELL POLARITY; CIGARETTE SMOKING; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; CONFERENCE PAPER; DISEASE ACTIVITY; DISEASE COURSE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENVIRONMENTAL FACTOR; EPITHELIUM CELL; HUMAN; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; PROTEIN SYNTHESIS INHIBITION; RETINA MACULA AGE RELATED DEGENERATION; RISK ASSESSMENT; SUBRETINAL NEOVASCULARIZATION;

COMPLEMENT MEMBRANE ATTACK COMPLEX; COMPLEMENT SYSTEM PROTEINS; FETUS; HUMANS; MACULAR DEGENERATION; OXIDATIVE STRESS; PRIMARY CELL CULTURE; REACTIVE OXYGEN SPECIES; RETINAL PIGMENT EPITHELIUM; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84855920488     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-0631-0_4     Document Type: Conference Paper

References (37)

1. Ablonczy Z, Crosson CE (2007) VEGF modulation of retinal pigment epithelium resistance. Exp Eye Res 85: 762-771 (Pubitemid 350166363)
2. Alon T, Hemo I, Itin A et al (1995) Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med 1: 1024-1028
3. Augustin AJ, Scholl S, Kirchhof J (2009) Treatment of neovascular age-related macular degeneration: Current therapies. Clin Ophthalmol 3: 175-182
4. Bailey TA, Kanuga N, Romero IA et al (2004) Oxidative stress affects the junctional integrity of retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 45: 675-684 (Pubitemid 38140530)
5. Bartlett H, Eperjesi F (2003) Age-related macular degeneration and nutritional supplementation: a review of randomised controlled trials. Ophthalmic Physiol Opt 23: 383-399 (Pubitemid 41711055)
6. Brown MM, Brown GC, Stein JD et al (2005) Age-related macular degeneration: economic burden and value-based medicine analysis. Can J Ophthalmol 40: 277-287 (Pubitemid 40942254)
7. Chen H, Lukas TJ, Du N. et al (2009) Dysfunction of the retinal pigment epithelium with age: increased iron decreases phagocytosis and lysosomal activity. Invest Ophthalmol Vis Sci 50: 1895-1902
8. Choudhary S, Xiao T, Srivastava S et al (2005) Toxicity and detoxifi cation of lipid-derived aldehydes in cultured retinal pigmented epithelial cells. Toxicol Appl Pharmacol 204: 122-134 (Pubitemid 40432370)
9. Dong A, Xie B, Shen J et al (2009) Oxidative stress promotes ocular neovascularization. J Cell Physiol 219: 544-552
10. Edwards AO, Fridley BL, James KM et al (2008) Evaluation of clustering and genotype distribution for replication in genome wide association studies: the age-related eye disease study. PLoS ONE 3: e3813. (Pubitemid 352749427)
11. Espinosa-Heidmann DG, Suner IJ, Catanuto P et al (2006) Cigarette smoke-related oxidants and the development of sub-RPE deposits in an experimental animal model of dry AMD. Invest Ophthalmol Vis Sci 47: 729-737 (Pubitemid 46768404)
12. Finnemann SC, Leung LW, Rodriguez-Boulan E (2002) The lipofuscin component A2E selectively inhibits phagolysosomal degradation of photoreceptor phospholipid by the retinal pigment epithelium. Proc Natl Acad Sci USA 99: 3842-3847 (Pubitemid 34252193)
13. Hadziahmetovic M, Dentchev T, Song Y et al (2008) Ceruloplasmin/ hephaestin knockout mice model morphologic and molecular features of AMD. Invest Ophthalmol Vis Sci 49: 2728-2736
14. Hageman GS, Anderson DH, Johnson LV, et al (2005) A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci USA 102: 7227-7232 (Pubitemid 40696361)
15. Haines JL, Hauser MA, Schmidt S et al (2005) Complement factor H variant increases the risk of age-related macular degeneration. Science 308: 419-421 (Pubitemid 40530081)
16. Klein RJ, Zeiss C, Chew EY et al (2005) Complement factor H polymorphism in age-related macular degeneration. Science 308: 385-389 (Pubitemid 40530070)
17. Lakkaraju A, Finnemann SC, Rodriguez-Boulan E (2007) The lipofuscin fl uorophore A2E perturbs cholesterol metabolism in retinal pigment epithelial cells. Proc Natl Acad Sci USA 104: 11026-11031 (Pubitemid 47175220)
18. Lee AY, Kulkarni M, Fang AM et al (2010) The effect of genetic variants in SERPING1 on the risk of neovascular age-related macular degeneration. Br J Ophthalmol 94: 915-917
19. Mata NL, Tzekov RT, Liu X et al (2001) Delayed dark-adaptation and lipofuscin accumulation in abcr+/? mice: implications for involvement of ABCR in age-related macular degeneration. Invest Ophthalmol Vis Sci 42: 1685-1690 (Pubitemid 32652338)
20. McKay GJ, Silvestri G, Patterson CC et al (2009) Further assessment of the complement component 2 and factor B region associated with age-related macular degeneration. Invest Ophthalmol Vis Sci 50: 533-539
21. Mulligan RM, Atkinson C, Vertegel AA et al (2009) Cigarette smoke extract stimulates interleukin- 8 production in human airway epithelium and is attenuated by superoxide dismutase in vitro. Am J Rhinol Allergy 23: 1-4
22. Pangburn MK (2000) Host recognition and target differentiation by factor H, a regulator of the alternative pathway of complement. Immunopharmacology 49: 149-157 (Pubitemid 30445226)
23. Rohrer B, Long Q, Coughlin B et al (2009) A Targeted Inhibitor of the Alternative Complement Pathway Reduces Angiogenesis in a Mouse Model of Age-related Macular Degeneration. Invest Ophthalmol Vis Sci 50: 3056-3064
24. Saint-Geniez M, Maharaj AS, Walshe TE et al (2008) Endogenous VEGF is required for visual function: evidence for a survival role on Muller cells and photoreceptors. PLoS ONE 3: e3554
25. Schmidt S, Hauser MA, Scott WK et al (2006) Cigarette smoking strongly modifies the association of LOC387715 and age-related macular degeneration. Am J Hum Genet 78: 852-864
26. Snodderly DM (1995) Evidence for protection against age-related macular degeneration by carotenoids and antioxidant vitamins. Am J Clin Nutr 62: 1448S-1461S
27. Sparrow JR, Fishkin N, Zhou J et al (2003) A2E, a byproduct of the visual cycle. Vision Res 43: 2983-2990 (Pubitemid 37377610)
28. Suner IJ, Espinosa-Heidmann DG, Marin-Castano ME et al (2004) Nicotine increases size and severity of experimental choroidal neovascularization. Invest Ophthalmol Vis Sci 45: 311-317 (Pubitemid 38055703)
29. Suter M, Reme C, Grimm C et al (2000) Age-related macular degeneration. The lipofusion component N-retinyl-N-retinylidene ethanolamine detaches proapoptotic proteins from mitochondria and induces apoptosis in mammalian retinal pigment epithelial cells. J Biol Chem 275: 39625-39630 (Pubitemid 32058989)
30. Takeuchi A, Takeuchi M, Oikawa K et al (2009) Effects of dioxin on vascular endothelial growth factor (VEGF) production in the retina associated with choroidal neovascularization. Invest Ophthalmol Vis Sci 50: 3410-3416
31. Thurman JM, Renner B, Kunchithapautham K et al (2010) Aseptic injury to epithelial cells alters cell surface complement regulation in a tissue specifi c fashion. Adv Exp Med Biol 664: 151-158
32. Thurman JM, Renner B, Kunchithapautham K et al (2009) Oxidative Stress Renders Retinal Pigment Epithelial Cells Susceptible to Complement-mediated Injury. J Biol Chem 284: 16939-16947
33. van Wijngaarden P, Qureshi SH (2008) Inhibitors of vascular endothelial growth factor (VEGF) in the management of neovascular age-related macular degeneration: a review of current practice. Clin Exp Optom 91: 427-437
34. Vives-Bauza C, Anand M, Shirazi AK et al (2008) The age lipid A2E and mitochondrial dysfunction synergistically impair phagocytosis by retinal pigment epithelial cells. J Biol Chem 283: 24770-24780
35. Voloboueva LA, Killilea DW, Atamna H et al (2007) N-tert-butyl hydroxylamine, a mitochondrial antioxidant, protects human retinal pigment epithelial cells from iron overload: relevance to macular degeneration. FASEB J 21: 4077-4086 (Pubitemid 350232364)
36. Wang AL, Lukas TJ, Yuan M et al (2009) Changes in retinal pigment epithelium related to cigarette smoke: possible relevance to smoking as a risk factor for age-related macular degeneration. PLoS ONE 4: e5304.
37. Wong RW, Richa DC, Hahn P et al (2007) Iron toxicity as a potential factor in AMD. Retina 27: 997-1003 (Pubitemid 350303998)